NXS 7.14% 22.5¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-10

  1. 221 Posts.
    lightbulb Created with Sketch. 121
    When you are growing at 80% compound per annum and adding new customers daily, to expect your quarterly cashflow from sales to equal your quarterly revenue is just silly. I doubt they have many customers who are on a cash only basis. Most of their customers would have negotiated at least 30 days and probably more to pay their accounts. A fair few of their customers are huge hospital groups or medical conglomerates. As a consequence, there will always be a lag between a sale and receipt of cash and in a business growing like the clappers, this is even more pronounced.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.015(7.14%)
Mkt cap ! $65.63M
Open High Low Value Volume
22.0¢ 24.5¢ 22.0¢ $85.34K 363.8K

Buyers (Bids)

No. Vol. Price($)
1 100000 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 10003 1
View Market Depth
Last trade - 15.42pm 25/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.